ȸ»ç¼Ò°³
|
¹®ÀÇ
|
ºñ±³¸®½ºÆ®
½ÃÀåÁ¶»çº¸°í¼
ÀÚµ¿Â÷
Åë½Å/IT
ÀüÀÚºÎǰ/¹ÝµµÃ¼
¿¡³ÊÁö/ȯ°æ
ÀǾàǰ
ÀÇ·á±â±â
Ç×°ø¿ìÁÖ/¹æÀ§
¸ÅÆ®¸®¾ó
½Äǰ/À½·á
»ê¾÷¿ë±â°è
ÀϹݼҺñÀç
ÀÎÇÁ¶ó
±ÝÀ¶/¹ðÅ·
¿¬°£Á¤º¸¼ºñ½º
¸ÂÃãÇü½ÃÀåÁ¶»ç
±Û·Î¹úÆÄÆ®³Ê
¸ÞÀϸµ¼ºñ½º
My Cart
Ȩ
>
±Û·Î¹ú ÆÄÆ®³Ê
> La Merie Publishing
Ä«Å×°í¸®
±Û·Î¹ú ÆÄÆ®³Ê
ÀÚµ¿Â÷
Åë½Å/IT
ÀüÀÚºÎǰ/¹ÝµµÃ¼
¿¡³ÊÁö/ȯ°æ
ÀǾàǰ
ÀÇ·á±â±â
Ç×°ø¿ìÁÖ/¹æÀ§
¸ÅÆ®¸®¾ó
½Äǰ/À½·á
»ê¾÷¿ë±â°è
ÀϹݼҺñÀç
ÀÎÇÁ¶ó
±ÝÀ¶/¹ðÅ·
La Merie Publishing
½ºÆäÀÎ ¹Ù¸£¼¿·Î³ª¿¡ º»»ç¸¦ µÐ La Merie´Â ¹ÙÀÌ¿À Å×Å©³î·¯Áö ¹× Á¦¾à »ê¾÷¿¡ ´ëÇÑ ¸®¼Ä¡¸¦ Àü¹®À¸·Î Çϰí ÀÖ½À´Ï´Ù.
Á¦¸ñ °Ë»ö
1
-
10
¸®ºä (Àüü£º
10
°Ç)
Á¤·Ä
¹ßÇàÀÏ
ÇѱÛÁ¦¸ñ
¿µ¹®Á¦¸ñ
°¡°Ý
Ç¥½Ã °Ç¼ö
25
50
100
ÇÁ·ÎÅ×¾ÆÁ», ¸®¼ÒÁ», ¿ÀÅäÆÄÁö °æ·Î¿¡ ÀÇÇÑ Ç¥Àû ´Ü¹éÁú ºÐÇØ(TDP)(2022³â) : ¾÷°è »óȲ ºÐ¼® - ÀÌÇØ°ü°èÀÚ, ±â¼ú, ÆÄÀÌÇÁ¶óÀÎ, Á¦ÈÞ, ÀÚ±Ý Á¶´Þ
Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: An Industry Landscape Analysis of Stakeholders, Technologies, Pipeline, Partnering and Financing
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
1064487
¹ßÇà
2022³â 03¿ù
ÆäÀÌÁö Á¤º¸
553 Pages
°¡°Ý
EUR 2,450 ->
£Ü 3,361,000
ÇÁ·Îµå·¯±× ¸¶½ºÅ© Ç×ü ¹× »çÀÌÅäÄ«ÀÎ ½ÃÀå : »ê¾÷ÀÇ °üÁ¡¿¡¼ º» ÀÌÇØ °ü°èÀÚ, ±â¼ú, ÆÄÀÌÇÁ¶óÀÎ, ºñÁî´Ï½º, ÀÚ±Ý Á¶´Þ µ¿Çâ
Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from an Industry Perspective
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
1031041
¹ßÇà
2021³â 10¿ù
ÆäÀÌÁö Á¤º¸
433 Pages
°¡°Ý
EUR 2,250 ->
£Ü 3,087,000
DNA¿Í mRNA¿¡ ÀÇÇÑ »ýü³» ¹ßÇöÀ» À§ÇÑ º¤ÅÍÈ Ç×ü ½ÃÀå : ÀÌÇØ °ü°èÀÚ¡¤±â¼ú¡¤Ç¥Àû¡¤ºñÁî´Ï½º¡¤±ÝÀ¶ Á¤¼¼ ºÐ¼® - ¾÷°èÀÇ °üÁ¡¿¡¼ ºÐ¼®
Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis of Stakeholders, Technologies, Targets, Business and Financing From an Industry Perspective
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
1017023
¹ßÇà
2021³â 07¿ù
ÆäÀÌÁö Á¤º¸
259 Pages
°¡°Ý
EUR 2,150 ->
£Ü 2,949,000
½Å¾à R&D ÆÄÀÌÇÁ¶óÀÎ µ¥ÀÌÅͺ£À̽º : ¿¬°£ ±¸µ¶
R&D Drug Pipeline Database: 1-Year Subscription
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
302689
¹ßÇàÁ¤º¸
¿¬°£±¸µ¶
ÆäÀÌÁö Á¤º¸
°¡°Ý
EUR 6,000 ->
£Ü 8,232,000
º¸°í¼ ÆÐŰÁö : ¾ðµå·¯°Åºí(Undruggable) ±â¼ú
Report Package - 4 for 2: "Drug the Undruggable" Technologies
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
936691
¹ßÇà
2020³â 05¿ù
ÆäÀÌÁö Á¤º¸
4 Reports
°¡°Ý
EUR 4,125 ->
£Ü 5,659,000
½ÅÈï ´Ü¹éÁú ºÐÇØ À¯µµ Ű¸Þ¶ó ´Ü¹éÁú(PROTAC) ¹× ºÐÀÚ Á¢ÂøÁ¦¿¡ ÀÇÇÑ Ç¥Àû ´Ü¹éÁú ºÐÇØ(TPD) : ¾÷°è »óȲ
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
936351
¹ßÇà
2020³â 05¿ù
ÆäÀÌÁö Á¤º¸
195 Pages
°¡°Ý
EUR 2,050 ->
£Ü 2,812,000
RNA Ç¥Àû ÀúºÐÀÚ(2019³â) : ±â¾÷, ±â¼ú, ¸ñÇ¥, ÅõÀÚ°¡, ÆÄÆ®³Ê·ÎºÎÅÍÀÇ ¾÷°è Àü¸Á
RNA-Targeted Small Molecules 2019: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
911032
¹ßÇà
2019³â 09¿ù
ÆäÀÌÁö Á¤º¸
223 Pages
°¡°Ý
EUR 2,050 ->
£Ü 2,812,000
º¸°í¼ ÆÐŰÁö - °æÀï»ç ºÐ¼® : ¾Ï¸é¿ª ¹× ±âŸ ÁúȯÀ» À§ÇÑ ÀÌÁß Æ¯À̼º Ç×ü, T¼¼Æ÷ ¹× NK(ÀÚ¿¬»ìÇØ)¼¼Æ÷¿Í °áÇÕÇÏ´Â ÀÌÁ߯¯À̼º Ç×ü(2019³â) : ºñÁö´Ï½º, ÀÌÇØ°ü°èÀÚ, ±â¼ú ¹× ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
2 Reports Bundle - Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases plus T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
890416
¹ßÇà
2019³â 06¿ù
ÆäÀÌÁö Á¤º¸
°¡°Ý
EUR 2,500 ->
£Ü 3,430,000
°æÀï»ç ºÐ¼® : ¾Ï¸é¿ª ¹× ±âŸ ÁúȯÀ» À§ÇÑ ÀÌÁß Æ¯À̼º Ç×ü
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
890224
¹ßÇà
2019³â 06¿ù
ÆäÀÌÁö Á¤º¸
125 Pages
°¡°Ý
EUR 800 ->
£Ü 1,097,000
T¼¼Æ÷ ¹× NK(ÀÚ¿¬»ìÇØ)¼¼Æ÷¿Í °áÇÕÇÏ´Â ÀÌÁ߯¯À̼º Ç×ü(2019³â) : ºñÁö´Ï½º, ÀÌÇØ°ü°èÀÚ, ±â¼ú ¹× ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis
¸®¼Ä¡»ç
La Merie Publishing
»óǰÄÚµå
868394
¹ßÇà
2019³â 06¿ù
ÆäÀÌÁö Á¤º¸
463 Pages
°¡°Ý
EUR 2,350 ->
£Ü 3,224,000
»ó±â ÀÚ·á ÀÌ¿ÜÀÇ
La Merie Publishing
ÀÚ·áµµ ÁÖ¹® °¡´ÉÇÏ´Ï
¹®ÀÇ
ÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.